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Chapter 1
Pyruvate Dehydrogenase Kinase Binding Study
INTRODUCTION
The pyruvate dehydrogenase complex (PDC) performs a central
function in carbohydrate oxidation and fatty acid synthesis. In
the presence of thiamin pyrophosphate (TPP) and Mg^+ , it catalyzes
the conversion of pyruvate to acetyl-CoA. This is a key step in
the oxidation of carbohydrate and is a rate limiting step in the
biosynthesis of fatty acid. This reaction involves the
coordinated functioning of three catalytic components: pyruvate
dehydrogenase (PDH or El), dihydrolipoyl transacetylase (E2) and
dihydrolipoyl dehydrogenase (E3). The individual steps catalyzed
by these components are given in the introduction to chapter 2.
The overall reaction can be represented by:
Pyruvate + CoA + NAD+ =^===^ Acetyl-CoA + C0 2 + NADH + H+
The pyruvate dehydrogenase component of PDC is regulated by
interconversion between an active, nonphosphorylated form and an
inactive, phosphorylated form (1) by two regulatory enzymes, PDH
kinase and PDH phosphatase that are associated with PDC (9).
The inner core of PDC is thought to be composed of 60
identical dihydrolipoyl transacetylase (E2) subunits (19). Each
subunit has two domains (1). The inner domain (E2j) of E2
associates to form the large oligomeric core and catalyzes the
transacetylation reaction (1). The outer domain (E2L ) is the
lipoyl-bearing region that participates in the transfer of the
1
acetyl group. Another protein referred to as protein X
(3,4,7,14,16) is tightly bound to the E2 core (14). Protein X is
structurally distinct from E2 subunit, and also has two domains:
an inner domain (Xj) which binds to E2 core, and a lipoyl-
containing outer domain (Xl) that undergoes reduction and
acetylation (17). Protein X lacks the transacetylation activity
of E2 subunits (15).
The pyruvate dehydrogenase kinase consists of a catalytic
subunit (Kc ) and a basic subunit (K^) (14,21). While the role of
K^ has not been well established, recent studies have shown that
an increase in kinase activity is correlated with the cleavage of
the K]-, subunit, suggesting that K^ might inhibit the activity of
Kc (17). Approximately three kinase molecules are bound to each
E2 core (7,14). The protein X and kinase subunits are both
tightly bound to E2 and are retained after the resolution process
that removes the El and E3 components (7,10). It also has been
demonstrated that the reduction and acetylation of protein X
prepared free of E2 subunits is associated with a small
enhancement of kinase activity (15). It was proposed that protein
X plays a role in attenuating kinase activity (15) and serves as
an anchor of kinase to the E2 core (14). However, a recent study
involving protease Arg C digestion of E2-X-KcKb revealed that
removal the outer domain from E2 subunit released Kc subunits,
thus providing evidence that the kinase is anchored on E2 directly
(17). In addition there is evidence that E3 subunits directly
associate with protein X (18).
Since it is not clear how protein X or kinase are bound to
the E2 core, it is interesting to characterize their ability
(following their removal) to reassociate with the E2 core
containing or lacking protein X and kinase molecules.
EXPERIMENTAL PROCEDURES
Ma t er ial s
:
Highly purified bovine kidney pyruvate
dehydrogenase complex (15—18 umole/mg/min) was resolved to E2-X—
K cKb subcomplex by the procedure of Linn et al . (10), X-KCK^
fraction by the procedure of Stepp et al . (21), E2—Xj was
generated by protease Arg C treatment (17). E2" (E2 with low
level of protein X) was resolved by urea and NaCl by the procedure
of Powers—Greenwood and Roche (unpublished procedure). Fig 1—1
diagrams these different preparations. [y P]ATP was from ICN
Biomedicals, Inc. [^C]ATP and [ l-l^C]acetyl-CoA were purchased
from New England Nuclear (NEN) Du Pont Company. Bovine serum
albumin (BSA) as protein standard was from U.S. Biochemical
Corporation. All other chemicals used were highest grade
available.
Kinase binding experiment : E2 component and kinase sources
were incubated at desired levels at room temperature in buffer
which contained 50 mM NaxP04, pH 7.5, 0.2 mM ethylenediamine
tetraacetic acid (EDTA) and 0.5 mM dithiothreitol (DTT) in a total
volume of 50 ul. After 15 min, the samples were overlaid on a
sucrose gradient in airfuge tubes. Sucrose step-gradients (7.5%,
10%, 15% w/v) were preformed in the same buffer as mentioned
above. The volume of the each step was 20 ul. Samples were
centrifuged in SW 29 rotor at 4°C, 151200xg for 90-120 min. After
centrifugation, supernatants were withdrawn and one half volume
(55 ul) of the same buffer was added to dissolve the pellet for 14
h on ice.
0—phthaldehvde protein measurement: The protein concentration
of each supernatant and pellet fraction was determined by the
procedure of Fried et al . (5). Excitation and emission
wavelengths were 330 nm and 418 nm respectively. BSA was used as
protein standard.
Kinase activity assay: Pyruvate dehydrogenase kinase activity
was determined as the initial rate of incorporation of -^P—
phosphoryl groups into protein from [y—^P]ATP (13). Assays were
conducted at 30°C in the buffer which contained 20 mM KXP04, pH
7.0, 1 mM MgCl 2 , 0.1 mM EDTA and 2 mM DTT. The order of addition
of the various components was as follows: El, E2-X subcomplex and
kinase source. The mixture was preincubated for 1—2 min and [y—
-^P]ATP (1-3x10-) cpm/nmole) was added to a final concentration of
100 uM to start the reaction. The total volume was 50 ul. At
designated time intervals, 20 ul was withdrawn and applied on a
dry disc filter paper presoaked with 10% trichloroacetic acid
(TCA) to stop the reaction. Three 30-min washes and another 14-h
wash with 10% TCA were done, then followed by two 5-min absolute
ethanol washes and two 2—min ethyl ether washes. Assays were done
in duplicates and average values were reported.
Transacetylation activity assay: The assays were conducted as
described by Butterworth et al . (2). Dihydrolipoyl transacetylase
catalyzes the transfer of the acetyl group of [l-^^C]acetyl-CoA to
dihydrolipoamide (DHL). The radioactive S—acetyl dihydrolipoamide
is extracted into benzene. The reaction mixture contained 25 mM
KXP04, pH 7.5, 0.5 mM DHL, 0.05 mM EDTA and 0.5 mM [ l-14C]acetyl-
CoA (6X10-5 cpm/umole) to make a total volume of 0.5 ml. The
reaction was started by the addition of [1— C]acetyl—CoA and the
mixture was incubated at room temperature for 2 min. 1 ml benzene
was added to stop the reaction. The mixture was shaken for 10 s
on a vortex to extract the S-acetyl DHL. A 0.2 ml aliquot of
benzene layer was withdrawn and radioactivity was measured by the
scintillation counting. All assays were done in duplicate.
ATP binding experiment: Binding of [ 14 C]ATP (97,000
cpm/nmole) to the PDH kinase was measured by the procedure of
Pratt et al
. (12). Millipore filters were presoaked with 5 mM ATP
in 20 mM KXP04, pH 7.0 to reduce nonspecific binding, then washed
with 5 ml of cold 20 mM KXP04, pH 7.0. The assays were done in
buffer containing 50 mM M0PS-K+ (3-(N-morpholine)propane sulfonic
acid) pH 7.3, 60 mM KC1 , 2 mM DTT, 1.5 mM MgCl 2 and 0.5 mM EDTA.
The kinase-containing fractions were added and the reactions were
started by the addition of [ 14C]ATP to the final concentration of
180 uM. The mixture was incubated at 22°C for 90 s in a total
volume of 25 ul. Then a 20 ul aliquot was withdrawn and applied
to the cold membrane filter, and immediately washed six times with
2 ml of cold 20 mM KXP04 buffer. After the membrane dried, the
radioactivity was measured. All assays were done in duplicate.
Sodium dodecvl sulfate polvacrvlamide gel electrophoresis
(SDS-PAGE)
:
SDS slab gel electrophoresis was performed under the
conditions described by Laemmli (8) with 10% acrylamide in the
running gel and 5% in the stacking gel. Bands were visualized
with a silver stain following the procedure by Oakley et al . (11).
RESULTS
Analysis of the binding of the kinase and protein X subunits to
the E2 core.
The binding of kinase to E2 subunits was studied with two
ratios of the X—
K
cKb fraction to E2-X—
K
cKb subcomplex. Figure 1—2
shows the gel pattern when the lower ratio of X—
K
cKb fraction to
E2—X—
K
cKb subcomplex was used. By comparing protein bands of the
pellet fraction (figure 1-2, X-KcKb/E2-X-KcKb : PI, P2) with the
standard E2-X-KcKb (figure 1-2, first six lanes), PI had about the
same amount of E2 component as E2-X-KcKb standard in lane 3 (0.4
Ug), also E2 band in P2 (half of the sample of PI loaded) matched
well the E2 band in lane 5 of E2-X-KcKb standard (0.2 ug). The Kc
bands of the PI and P2 pellets showed a large increase in the
level of Kc relative to the original E2-X-KcKb subcomplex. Even
when the P2 was compared to the highest level of the E2-X-KcKb
(which had three times E2), there was a higher level of Kc
present
.
The supernatant fraction (figure 1-2, X-KcKb/E2-X-KcKb : S)
had some residual kinase which indicated that it was not as
tightly associated with the E2 core. It was uncertain whether
this reflected saturation of kinase binding sites, the binding
equilibrium, or some damage to a portion of the kinase molecules
during preparation. In order to determine whether the E2 binding
with kinase had reached the maximum capacity, a higher ratio of X-
KcKb fraction/E2-X-KcKb subcomplex was incubated, centrifuged and
analyzed by SDS-PAGE (figure 1-3). The same pattern of E2-X-KcKb
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subcomplex standards was used (figure 1-3, first six lanes). The
gel pattern showed even more kinase (Kc ) subunits binding to the
E2-X-KcKb subcomplex (fig 1-3, X-KcKb/E2-X-KcKb : PI, P2, P3).
Again a significant increase in protein X binding was not
detected. More kinase remained in the supernatant (Figure 1—3, X—
KcKb/E2—X—
K
cKb : S), presumably due to an excess of added kinase,
although the alternative explanation mentioned above may still be
relevant.
While additional kinase was bound to E2—X—
K
cKb subcomplex,
there was little or no increase in the amount of protein X
associated with the E2-X-KcKb subcomplex. This brought up the
question concerning the nature of the association of protein X
with the E2 core. It was found in the above experiments that the
amount of protein X associated with E2 core did not significantly
increase along with the increased binding of Kc , but it is not
clear whether the protein X subunit in the X-KcKb fraction can
undergo exchange with those on the E2 core or whether protein X
occupies sites not available for reversible protein X binding.
In an attempt to clarify these questions, another binding
experiment was conducted with the E2-Xj subcomplex in which the
outer domain of protein X was removed but the inner domain still
occupied the protein X sites on the E2 core and the E2* which is a
form of the E2 oligomer with most of protein X removed. The
results are shown in figure 1-4. Again increased Kc binding was
observed. However little or no protein X present in X-KcKb
fraction was bound to E2* and E2-Xj subcomplex (Figure 1-4, X-
KcKb/E2-X!: PI, P2, P3; X-KcKb/E2*: PI, P2, P3). These results
suggested that the protein X in the X-KcKb fraction did not
exchange with the inner domain of protein X (Xj) that occupied the
protein X binding sites; protein X did not bind to available sites
on E2" either. However the possibility that protein X was damaged
during the resolution steps and therefore lost the ability of
binding to E2 core can not be eliminated.
PDH kinase binding sites on the E2 core.
In order to determine the number of PDH kinase molecules
bound per E2 core and to evaluate whether the unbound kinase in
the supernatant was still native, kinase ATP binding and specific
activity studies were conducted.
The ATP binding capacity of the kinase was determined for all
the kinase containing fractions. The initial content of Kc in the
E2-X-KcKb subcomplex and the amount of X-KCKD fraction added set
the lower and the upper limits for the amount of kinase that could
be bound. Measurement of the ATP binding of the pellet fractions
from the first and the second experiments confirmed increased
capacity for binding of ATP (3 and 5.5 fold respectively) (Table
1-1). The kinase remaining in the supernatants also exhibited the
ability to bind the ATP.
Although kinase was still capable of binding ATP, it is
important to examine its catalytic function to see whether it is
native. The kinase activity of each fraction was measured. To
attempt to assure full expression of kinase activity, E2-X
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subcomplex was added in some assays. The capacity of the E2—
X
subcomplex to increase kinase activity is recognized from the
difference between the activities of the samples assayed with and
without E2-X subcomplex (table 1-1). Also the activation of the
large number of Kc associated with the E2 core present in the
pellet fractions is evaluated without extra E2-X subcomplex in the
assay.
When measuring the specific activity, it is important to
determine the initial velocity. Since a large number of kinase
molecules are present in the pellet fractions, substrate (pyruvate
dehydrogenase component) depletion is a potential problem. Thus
it was necessary to keep the reaction time as short as possible so
that there would be only a few turnovers before the substrate
depletion occurs. After a few turnovers, the exchange between the
free active pyruvate dehydrogenase and bound inactive pyruvate
dehydrogenase on the E2 core could be the rate limiting factor.
Actually, in the pellet fractions, large kinase activations
by E2-X subcomplex were not observed (table 1-1
.
, numbers in the
parenthesis). This is informative since pellet fractions
contained E2-X subcomplex. The calculations of specific activity
of kinase per ATP binding were made from ATP binding and kinase
specific activity study of the two pellet fractions, the numbers
ranged from 30-40. This is similar to the range (27-34) reported
for the kinase associated with PDC complex, the E2-X-KCK D
subcomplex and the X-KcKb fraction in another study (14). This
suggested that the kinase in the pellet fractions maintained full
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activity, also the El associated with the E2 core were being made
available to the large number of kinase molecules.
However, the kinase in the supernatant of lower X—
K
CK^
fraction/E2—X—K^]-, subcomplex was not activated. Kinase in the
supernatant of higher X—
K
CK^ fraction/E2—X—
K
CK^ subcomplex was
activated a little, but not as much as expected. Since Kc did not
exhibit activation by E2-X, it is possible that free kinase lost a
portion of its catalytic capacity. Earlier experiment did show
that kinase in the supernatant fractions had the ability to bind
ATP. A factor that may have contributed to the low kinase
activity and its lack of activation was that the kinase was stored
frozen in a small aliquot for more than two weeks prior to the
kinase activity assays. It is not certain whether this activity
loss occured during that storage or reflected a defective portion
of the Kc in the initial X-KcKb fraction. However it is known
that the kinase in the X-KcKb fraction is less stable to freezing
and thawing than the kinase associated with the E2-X subcomplex
(unpublished observation).
Based on the kinase ATP binding and E2 activity studies,
calculations were made to estimate the maximum numbers of kinase
bound to E2 (Table l-II). The binding number determined from the
pellets in which the lower X-KcKb fraction/E2-X-KcKt, subcomplex
experiment was about 9 kinase molecules per E2 core. Based on the
amount of X-K cKb fraction and E2-X-KcKb subcomplex used, the
maximal possible binding was about 10. Since essentially all the
kinase available was bound, it was not certain if the outcome
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reflected saturation of the potential binding sites for kinase.
The experiment was repeated using the higher X—
K
CK^ fraction/E2—X—
KcKb subcomplex attempting to increase the Kc binding to E2. The
maximum possible kinase binding was 27. This time a number of
about 16 kinase molecules bound to each E2 core was derived.
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DISCUSSION
It is known that protein X and PDH kinase associate tightly
with the E2 core to form E2-X-KCK^ subcomplex. However how these
components are organized is not well known. There are about 6
protein X components bound to the E2 core (7). It was proposed
that protein X serves as the anchor through which the PDH kinase
is attached to E2 core (14). This was based on the result of
previous studies of the activation of the kinase. The experiments
were performed with E2—X subcomplex and X—
K
CK^ fraction. A fixed
level of E2—X subcomplex and pyruvate dehydrogenase component was
titrated with kinase. The data indicated that the E2-X subcomplex
had a high capacity for activation of the kinase in the X-KCK^
fraction. Since kinase must be bound to the E2 core to be
activated, the increased kinase activity reflected the increase in
kinase binding.
Whether this increased kinase activity was due to the extra
protein X binding which may serve as an anchor for kinase or was
due to the direct kinase binding to the E2 core was not clear.
Also an earlier binding experiment done with E2-X subcomplex and
X-K cKb fraction provided evidence that along with increased
binding of kinase, that there was an increase in the binding of
protein X to the E2 core in the pellet fraction (unpublished
observation). This observation was consistent with the suggestion
that protein X played an anchor role in the kinase binding to the
E2 core.
To further study the nature of protein X and kinase binding
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to the E2 core, binding experiments were conducted using E2-X-KC K]-,
subcomplex, E2-Xj subcomplex, E2X and X-KCK^ fraction. Great care
was invoked in the preparation of the X-KcKb fraction to
thoroughly remove the mercurial agent in its preparation. From
the SDS gel patterns of E2—X—
K
CKD subcomplex binding with X—
K
cKb
fraction (figure 1—2, 1—3), it is obvious that the amount of
kinase bound to the E2 core increased significantly. However, an
increased protein X level was not observed. This suggested that
kinase associated with E2 directly instead of through protein X.
It is also possible that each protein X component has the ability
to bind more kinase molecules. But this possibility was
eliminated by the binding experiments done with two other
fractions. E2-Xj subcomplex and E2* exhibited the same ability to
bind kinase (figure 1-4). These results provided the evidence
that kinase was bound to E2 core directly. Since previous data
showed that kinase did not bind to the inner domain of E2 (E2j)
(14), it might anchor to the lipoyl-bearing domain (E2l). Another
study found that removal of outer domains from E2 subunit released
the Kc subunits of kinase (17).
The experiments done above strongly suggested that protein X
was not involved in the kinase binding to E2 core. How protein X
binds to E2 core is not well understood. Although the structure
of protein X is distinct from the E2 subunit, the peptide mapping,
sequencing and immunological studies revealed that they have
structurally distinct but related lipoyl domains (7,18). The
kinase binding experiments done with E2-Xj subcomplex and E2*
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provided new insights into the possible nature of that protein X
binding. It is evident that the protein X in the X—
K
cKb fraction
neither underwent exchange with the inner domain of protein X (Xj)
associated with E2 core nor occupied the available protein X
binding sites in E2X fraction from the SDS gel analysis. It seems
reasonable to speculate that instead of being associated with the
periphery of the E2 core, protein X component may be integrated
into E2 subunits as part of the E2 core. If this is the case, it
would be of interest to investigate how the E2 core with protein X
is assembled and whether there is a fixed number of protein X
molecules assembled into each E2 core. Another less intriguing
possibility is that protein X in the X-KcKb fraction was denatured
by the treatment of organic mercurial reagent during the
resolution steps, therefore losing its binding ability. But the
same X-K c Kb fraction was shown to bind the E3 component
(unpublished results), which suggests that protein X has preserved
a major portion of its native structure. Although protein X
probably does not participate in kinase binding, reduction and
acetylation of its lipoyl domain in the absence of the E2 subunits
was associated with a small activation of the kinase (15). The
latter study was also performed with the X-KcKb fraction and
further indicates that the protein X in the fraction maintained
some native structure (18).
The control fractions (E2-X-KcKj) subcomplex, E2-Xj subcomplex
and E2" centrifuged alone) did not pellet as well as the fractions
containing X-KcKt,. Although the binding of kinase to the E2 core
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must increase the molecular weight of the subcomplex, this
increase would be expected only to be from 3.6x10" to about
4.4x10" which could not account for the observed increase in the
sedimentation.
Combining the results from kinase activity assay, kinase ATP
binding and E2 transacetylation activity assay, a maximum of 16
kinase molecules was bound to each E2 core. In both lower X-KcKb
fraction/E2-X-KcKb subcomplex and higher X-KCK^ fraction/E2-X-KcK]D
subcomplex experiments, there was a trace and moderate amount of
kinase remaining in the supernatant fractions. It was necessary
to examine whether these kinase still possessed the native
properties. The kinase ATP binding study revealed that it
preserved ability to bind ATP and the amount of ATP bound was
proportional to the kinase present in each supernatant fractions.
But when its catalytic function was examined, little kinase
activation was observed. This indicated that kinase in the
supernatant had lost its ability to be activated. It is not clear
what caused this loss in activation capacity. Perhaps the kinase
in the supernatant fractions was denatured during storage, which
included freezing and thawing. In contrast, the kinase in the
pellet fractions maintained a high activity. It is possible that
kinase may be stabilized and maintain its high activity at the
presence of E2 subunits.
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Fi gure 1-1. Scheme of the stages in the purification and
resolution steps in the preparation of pyruvate dehydrogenase
complex and resolved components.
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Figure 1-2. SDS-PAGE of PDH kinase binding using lower X-KcKb
fraction/E2-X-KcKb subcomplex. X-KcKb fraction (40 yg) and E2-X-
KcKb subcomplex (60 ug) were incubated at room temperature for 15
min, then loaded on sucrose gradient and centrifuged. The samples
were analyzed by SDS-PAGE and visualized by silver gel staining
(refer to experimental procedures for details). First six lanes
from left are E2-X-KcKb subcomplex standards, protein levels
loaded decreasing from 0.6 ug to 0.1 yg; X-KcKb/E2-X-KcKb : S_is
the supernatant fraction (0.34 yg) of lower X-KcKb fraction/E2-X-
KcKb subcomplex; X-KcKb/E2-X-KcKb : Pl f P2 are pellet fraction of
lower X-KcKb fraction/E2-X-KcKb subcomplex, the two protein levels
(0.4 yg, 0.2 yg) were loaded in order to precisely compare with
E2-X-KcKb subcomplex standards; E2-X-KcKb : S is the supernatant
fraction (0.12 yg) of control E2-X-KcKb subcomplex; E2-X-KcKb ; P
is the pellet fraction (0.56 yg) of control E2-X-KcKb subcomplex;
X-KcKfa : S is the supernatant fraction (0.44 yg) of control X-KcKb
fraction; X-KgKfa.LJl is the pellet fraction (0.02 yg) of control X-
KcKb fraction; X-KcKb is X-KcKb fraction, two levels were loaded
(1.0 yg, 0.5 yg); PDC is pyruvate dehydrogenase complex (1.0 yg)
.
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Figure 1-3. SDS-PAGE of PDH kinase binding using higher X-
KcKb fraction/E2-X-KcKb subcomplex. X-KcKb fraction (60 Ug) and
E2-X-KcKb subcomplex (30 ug) were used in the binding experiment
as mentioned in the legend of figure 1-2. First six lanes from
left are E2-X-K cKb subcomplex standards (0.6 ug-0.1 ug); X-
KcKb /E2-X-KcKb : S is the supernatant fraction (0.46 ug) of higher
X-KcKb fraction/E2-X-KcKb subcomplex; X-KcKb/E2-X-KcKb ; PI. P2 T P3
are pellet fraction of higher X-KcKb fraction/E2-X-KcKb subcomplex
loaded at three levels (0.58 ug, 0.29 Ug, 0.14 ug); E2-X-KcKb ; S
is the supernatant fraction (0.18 ug) of control E2-X-KcKb
subcomplex; E2-X-KcKb : P is the pellet fraction (0.21 ug) of
control E2-X-KcKb subcomplex; X-KcKb : S is the supernatant
fraction (0.44 ug) of control X-KcKb fraction; X-KcKb : P is the
pellet fraction (0.02 ug) of control X-KcKb fraction; X-Y^K^ is
the X-KcKb fraction loaded at two levels (1.0 ug, 0.5 ug); PDC is
pyruvate dehydrogenase complex (1.0 Ug).
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Fi gure 1-4. SDS-PAGE of PDH kinase binding with E2-X
];
subcomplex and E2'"~ subcomplex. 10 ug X-KcKb fractions were
incubated with 20 ug E2-Xj subcomplex and 20 ug E2* subcomplex
repectively, binding experiments were performed essentilly the
same as described before; First four lanes from left are E2-X-KcKb
subcomplex standards (0.4 ug-0.1 ug); X-KCK^/E2-Xi : S is the
supernatant fraction (0.36 ug) of X-KcKb f raction/E2-X];
subcomplex; X-KcKb/E2-XI : PI. P2. P3 are three levels of the
pellet fraction (0.9 ug, 0.45 ug, 0.2 ug) of X-KcKb fraction/E2-X:
subcomplex; X-KcKb/E2*: S is the supernatant fraction (0.48 ug) of
X-KcKb fraction/E2* subcomplex; X-KcKb/E2*: PI. P2. P3 are three
levels of the pellet fraction (0.7 ug, 0.35 ug, 0.2 ug) of X-KcKb
fraction/E2" subcomplex; X-KcKb : S is the supernatant fraction
(0.24 ug) of control E2-Xj subcomplex; X-KcKb : P is the pellet
fraction (0.45 ug) of control E2-X
z subcomplex; E2*: S is the
supernatant fraction (0.48 ug) of control E2* subcomplex; E2*: P
is the pellet fraction (0.33 ug) of control E2* subcomplex; X-KcKb
is X-KcKb fraction (1.0 ug); PDC is pyruvate dehydrogenase complex
(1.0 Ug).
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Table 1-1 . PDH kinase ATP binding capacity f specific activity
and transacetylation activity in various kinase—containing
fractions.
Fraction [ 14C]ATP
Bound3
(nmole/mg)
Specific
Activity"
(nmole/min/mg)
E2
Activityc
( nmole/min/mg)
E2-X-KcKb 0.50 9.1 4.4
X-KcKb 3.28 - -
Lower
X-KcKb/E2-X-KcKb
Supernatant
Pellet
0.51
1.35
16.5 (17.6) d
54.3 (49.7) d 2.6
Higher
X-KcKb/E2-X-KcKb
Supernatant
Pellet
1.53
2.84
39.1 (26.5) d
84.9 (56.9)d 2.9
aPDH kinase ATP binding was measured with 180 uM [ 14C]ATP under
the conditions described in methods. 12.2 ug E2-X-KcKb
subcomplex, 4.0 ug X-KcKb fraction, 5.1 ug supernatant and 7.8 Ug
pellet fraction of lower X-KcKb fraction/E2-X-KcKb subcomplex, 6.9
Ug supernatant and 8.7 ug pellet of higher X-KcKb fraction/E2-X-
KcKb subcomplex was used respectively with each assay.
bPDH kinase activity were corrected for low kinase activity in El
component and E2-X subcomplex. 22 ug El component, 5 ug E2-X
subcomplex were used in the assay. Kinase-containing fractions
added were as follows: 0.51 ug supernatant or 1.2 ug pellet
fraction of lower X-KcKb fraction/E2-X-KcKb subcomplex, 0.46 ug
supernatant or 1.2 Ug pellet fraction of higher X-KcKb
fraction/E2-X-KcKb subcomplex, for kinase in E2-X-KcKb subcomplex,
5 ug E2-X-KcKb subcomplex was assayed with 22 ug El component
only.
^E2 activity was carried out at the presence of 0.5 mM [1-
14C]acetyl-CoA and 0.5 mM DHL. Amount of each E2 source added was
as follows: 6.1 ug E2-X-KcKb subcomplex, 3.9 ug pellet fraction of
lower X-KcKb fraction/E2-X-KcKb subcomplex, 4.1 ug pellet fraction
of higher X-KcKb fraction/E2-X-KcKb subcomplex.
Numbers in the parenthesis represent the kinase activity assayed
without addition of E2-X subcomplex.
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Table l-II. Number of PDH kinase binding sites on E2
determined from lower X-KcKb fraction/E2-X-KcKb subcomplex and
hi gher X-KcKb fraction/E2-X-KcKb subcomplex binding experiments.
Fraction
ATP binding
site
Max. possible ATP
binding site
E2 core E2 core
Lower X-KcKb/E2-X-KcKb
Pellet Fraction
higher X-KcKb/E2-X-KcKb
Pellet Fraction 16
10
27
Calculation is based on the ATP binding site per E2 catalytic
unit.
Calculation of kinase binding sites of higher X-KcKb/E2-X-KcKb
pellet fraction
1) E2-X-KcKb subcomplex:
(0.5 nmole ATP/mg) /(4. 4 E2 unit/mg) =0.11 nmole ATP/E2 unit
2) Pellet fraction of higher X-KcKb/E2-X-KcKb :
(2.84 nmole ATP/mg)/(2.9 E2 unit/mg) = 0.98 nmole ATP/E2 unit
3) Kinase binding percentage increase:
(0.98 nmole ATP/E2 unit)/(0.11 nmole ATP/E2 unit) x 100%
= 890%
4) Assume molecular weight of E2-X-KcKb subcomplex is
3.7x10", the kinase molecules present in the subcomplex is:
0.5 nmole ATP/mg E2-X-KcKb x 3.7xl0 6 mg/mmole
=1.85 mole ATP/mole E2 core
5) Number of kinase molecules bound:
1.85 x 890% = 16 mole ATP/mole E2 core
Maximum possible kinase binding sites calculation
1) kinase units in X-KcKb fraction:
3.28 nmole ATP/mg x 0.06 mg = 0.1968 nmole ATP
2) Kinase units in E2-X-KcKb subcomplex:
0.5 nmole ATP/mg x 0.03 mg = 0.015 nmole ATP
3) Total kinase units:
0.1968 + 0.015 = 0.2118 nmole ATP
4) Total E2 catalytic units:
4.4 E2 unit/mg x 0.03 mg = 0.132 E2 units
5) The ratio of kinase units:E2 units:
0.2118 nmole ATP/0.132 E2 unit = 1.60 nmole ATP/E2 unit
6) Maximum possible kinase binding percentage increase:
(1.60 nmole ATP/E2 unit)/(0.11 nmole ATP/E2 unit) x 100%
= 1458%
7) Mamimum possible kinase binding sites:
1.85 x 1458% = 27 mole ATP/mole E2
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Chapter 2
Study of Reductive Acetylation Reaction
INTRODUCTION
Pyruvate dehydrogenase complex catalyzes a series of
coordinated reactions (figure 2—1):
CH3COCOOH + [TPPl-El >
[CH3C(0H)=TPP]-E1 + CO2 (1)
[CH3C(0H)=TPP]-E1 + [lipS 2 l-E2 ^= =»
[CH3C0-S-lipSH]-E2 + [TPP]-E1 (2)
[CH3C0-S-lipSH]-E2 + CoA-SH — —
^
[lip(SH) 2 ]-E2 + CH3C0-S-CoA (3)
[lip(SH) 2 ]-E2 + [FAD]-E3 ^= »
tlipS2 ]-E2 + reduced [FAD]-E3 (4)
reduced [FAD]-E3 + NAD+ =======^
[FAD]-E3 + NADH + H+ (5)
The pyruvate dehydrogenase (El) component catalyzes reactions 1
and 2. The dihydrolipoyl transacetylase (E2) component catalyzes
reaction 3. Reaction 4 and 5 are catalyzed by the dihydrolipoyl
dehydrogenase (E3) component.
A side reaction which is catalyzed by the El component is
stimulated by acetaldehyde to make acetoin:
[CH3C(0H)=TPP]-E1 + CH3CH0 ^ ^
CH3CH(0H)C0CH3 + [TPP]-E1 (6)
All the reactions are reversible except the decarboxylation of
pyruvate in reaction 1.
PDH isolated from bovine kidney and heart PDC has an a2 3 2
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tetramer structure (1). The approximate molecular weights of the
a subunit and B subunit are 41,000 and 36,000 respectively.
Pyruvate dehydrogenase kinase catalyzes the phosphorylation and
inactivation of pyruvate dehydrogenase component (3,6).
Phosphorylation covalently modifies the a subunit of PDH (1), but
the mechanism by which this leads to inhibition of the overall
reaction is not established. PDH phosphatase, another regulatory
enzyme loosely associated with PDC, dephosphorylates the inactive
form of PDH and converts it into the active form (4).
The El catalyzed decarboxylation reaction requires thiamin
pyrophosphate (TPP) binding to the El component. Phosphorylation
of the El a subunit increases its K^ for TPP about 2-fold (from 7
UM to 15 uM) (8). Reaction of a lysine residue of the El a
subunit with pyridoxal 5'-phosphate inhibited the PDH activity and
caused a 50-fold increase in K^ for thiamin-PP (7). Thus it is
likely that TPP is bound primarily or exclusively by the El a
subunit.
Phosphorylation of the PDH component markedly inhibited the
PDC overall reaction with pyruvate as substrate, but when HETPP
was used, there was no effect on the much slower rate of the
reductive acetylation reaction (reaction 2) (6). The
decarboxylation of pyruvate (reaction 1) was inhibited due to the
phosphorylation of the a subunit. Based on this observation, it
was proposed that the a subunit, which bears the phosphorylation
sites, catalyzes the decarboxylation reaction, and the 6 subunit
catalyzes the reductive acetylation reaction. However, the role
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of each subunit has not been established yet, apparently due to
difficulties in obtaining native a and B subunits of El component.
Interest in testing the potential catalytic function of the
El B subunit was stimulated by the finding that the El a subunit
could be selectively cleaved by trypsin and that the residual El B
subunit retained the capacity to bind to E2 subunits (reference
(18) in Chapter 1).
The PDC can slowly catalyze the reverse of the reductive
acetylation reaction. This 'partial back, reaction' was studied by
Walsh et al
. (8). This is a TPP dependent and acetyl-CoA
dependent reaction. Walsh et al . measured the rate of acetyl-CoA-
dependent oxidation of NADH in the presence of acetaldehyde which
would react with the hydroxyethylidene thiamin pyrophosphate
(HE=TPP) to yield acetoin. A basal oxidation of NADH was present
and the correction for this background was significant. An assay
which directly measures the yield of acetoin, a by-product formed
by HE=TPP with acetaldehyde of reaction 6 following the reverse of
the reductive acetylation reaction catalyzed by El (reverse of
reaction 2) was developed in this study to attempt to gain insight
into the function of El B subunit and the effect of
phosphorylation on the PDC catalyzed reverse reaction.
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MATERIALS AND METHODS
Materials: PDC was isolated from bovine kidney and separated
into its component enzymes as described by Linn et al . (5). The
El 8 subunit-rich fraction was obtained by trypsin treatment and
ammonium sulfate fractionation. [ l-^C]acetyl-CoA was purchased
from NEN Du Pont Company. Dowex 1-X8 anion exchange resin (20-50
mesh, chloride form) was from Bio-Rad. Organic acid analysis
column used to separate acetoin was from Bio-Rad. All other
chemicals used were the highest grade available.
Inactivation of pyruvate dehydrogenase complex: 0.1 ml PDC
(17.9 mg/ml) was incubated with 0.6 mM ATP and 3 mM MgCl2 at 30°C
for 10 min and then on ice for 15 minutes. A G-50 sephedax column
was used to remove the excess ATP.
Reverse reductive acetvlation assay: The assay was conducted
in a reaction mixture containing 0.5 mM TPP, 1 mM NADH, 0.4 mM
NAD+
,
1 mM MgCl 2 , 0.5 mM EDTA (ethylenediamine tetraacetic acid),
5 mM acetaldehyde, 50 mM KXP04, pH 7.5 and 0.2 mM [ l-14C]acetyl-
CoA (20,000 cpm/nmole) in a total volume of 0.1 ml. Purified PDC
or resolved PDC subcomplexes were added at indicated levels. The
reaction was initiated by adding [ l-^Cjacetyl-CoA. The mixture
was incubated in water bath at 30°C. At designated time
intervals, a portion of the reaction mixture was withdrawn and the
reaction was terminated by addition of perchloric acid (PCA) to a
final PCA concentration of 4%. After incubation on ice
, the
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protein was pelleted by centrifugation in a minifuge (8000xg).
This was repeated until no visible precipitate was present in the
supernatant. The PCA in the supernatant was removed by
neutralizing with KOH and potassium salt was pelleted by
centrifugation in a minifuge several times until all the visible
salt was removed. This solution, containing both radioactively
labeled acetyl—CoA and acetoin, was loaded on anion exchange
column and equilibrated for 2-3 min for the absorption of acetyl-
CoA onto the anion exchange resin. The sample was collected by
centrifugation from the column in a clinical centrifuge. To
reduce the non-specific acetoin binding on the resin, the column
was rinsed with 50 mM non-radioactive ('cold') acetoin solution
before the fraction containing the radioactive acetoin was
applied. The used resin was regenerated by rinsing the column
with large volume of concentrated HC1 to elute bound acetyl-CoA.
Acetyl-CoA sticks to the radioactivity detector cell and may cause
problems in the radioactivity detection system (see below).
Acetoin detection by high performance liquid chromatography
(HPLC): The sample was analyzed using an isocratic HPLC system.
An organic acid column for separating small organic molecules was
employed. Filtered and degassed 0.01 N H2SO4 was used as solvent
and the flow rate was set at 0.8 ml/min. The radioactive acetoin
was detected by Packard Trace 7140 radioactivity flow monitor.
The acetoin had a characteristic retention time of about 15
minutes (Figure 2-3).
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RESULTS
Ra te of the reverse reaction.
The reverse of the reductive acetylation reaction was carried
out with high NADH:NAD+ ratio (2.5), high concentration TPP (0.5
mM) and acetaldehyde (5 mM) to drive it backward to produce
acetoin. The time course of this reaction was shown in figure 2-
4. The rate of acetoin production was 0.11 umole/mg PDC/min.
The function of El 8 subunit.
The role of El 8 subunit was studied by this reverse
reaction. The trypsin treatment of El cleaved El a subunit and
generated a fraction that was rich in El 8 subunit. The El 8
subunit was found to bind E2 subunit indicating that 8 subunit
retained native structure. El 8 subunit was reconstituted with E2
and E3 in reaction mixture and incubated at 30°C for 2 hours.
There was no observable acetoin produced; whereas when intact El
component was reconstituted with E2 and E3, the full activity was
restored. This indicated that El 8 subunit alone was not able to
catalyze the reaction.
The effect of PDC phosphorylation on the reverse reaction.
Two assays were conducted, one used 16 ug phosphorylated PDC,
the other used 14.5 ug nonphosphorylated PDC as control. Both
reactions were incubated at 30°C for 2 hours. Acetoin production
was completely inhibited in the one done with phosphorylated PDC,
while the nonphosphorylated PDC catalyzed the reaction.
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DISCUSSION
Although it is well known that phosphorylation of pyruvate
dehydrogenase (El) component greatly inhibits the overall PDC
catalyzed reaction, how and at which step it causes inhibition is
still not fully characterized yet.
Walsh et al
. (8) studied the 'partial back reaction' using
NADH oxidation assay. This reaction gave a background of NADH
oxidation due to the reduction of E2 lipoyl domain without being
acetylated. The reaction rate was determined to be 0.055
ymole/min/mg. The rate is slower than the rate measured in this
study (0.11 umole/min/mg)
. Since the PDC they used was about one
half of the specific activity used in this study, the reaction
rates may be similar. In both studies acetaldehyde was used as an
acceptor for HE=TPP formed to speed up the reaction. The reverse
of the reductive acetylation reaction developed in this study used
acetaldehyde to trap HE=TPP and form acetoin as a product, and by
removing this product the back reaction was enhanced. This was
achieved by using a reaction mixture containing high ratio of
NADH/NAD"1", high TPP concentration to facilitate its binding to El
(tTPP]-El). The acetyl group from acetyl-CoA was transferred to
[TPP] -El to form [HETPP]-E1, probably in the hydroxyethylidene
form, in the presence of acetaldehyde and H+
, acetoin was formed.
Apparently contradictory results were obtained from the study
of the reductive acetylation reaction by Roche et al . and Walsh et
al
.
(6,8). This reaction is the rate-limiting step of the PDC
catalyzed overall reaction (2). Roche et al . used HETPP as
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substrate and studied the reductive acetylation reaction as a
model reaction. This reaction is much slower than the PDC
catalyzed reductive acetylation reaction. They demonstrated that
phosphorylated PDC inhibited the overall reaction when pyruvate
was the substrate, but when HETPP was added as substrate, the
utilization of HETPP was not affected by phosphorylation using
NAD+ reduction assay. Reductive acetylation assay revealed that
phosphorylation of El a subunit inhibited the pyruvate
decarboxylation reaction, but not reductive acetylation reaction
(6).
Randle et al
.
studied the effects of phosphorylation on PDC
and they came to the conclusion that all reactions in which
[HE=TPP]-E1 was formed were inhibited by phosphorylation of the
enzyme and no reaction in which [HE=TPP]-E1 was not involved was
affected (8). In the present study phosphorylation of PDC
eliminated the acetoin production by reverse reaction completely.
Thus the result seems to agree with their observation.
There are some differences between the forward and reverse
reactions. In the reverse reaction [HE=TPP]-E1 reacts with
acetaldehyde to form acetoin and TPP-E1 , TPP-E1 can then be
directly used in next round reaction (figure 2-2). When HETPP is
used as substrate in the forward reaction, the rate limiting step
is either deprotonation of [HETPP]-E1 to form [HE=TPP]-E1, or TPP
dissociation from El component so that El subunit can be recycled
to bind HETPP (figure 2-2).
However because these reactions involving HETPP are complex
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and have multiple steps, it is still not clear how phosphorylation
inhibits these reactions. The phosphorylation increases K^ of El
for TPP about two—fold, however this increase seems inadequate to
account for the large activity difference between the active and
inactive forms of PDC.
Several possible explanations are considered based on the
observations mentioned above. Firstly, although phosphorylation
of the El a subunit does not affect the TPP binding greatly, it
may alter the orientation of bound TPP. Secondly, phosphorylation
may modify the decarboxylation active site on the El component,
thus blocking the ability of TPP-E1 to catalyze the
decarboxylation of reaction 1, or alter the reductive acetylation
active site, so inhibiting the acetyl group transfer of reaction
2. Another possibility is that phosphorylation blocks the HE=TPP
translocation between the two active sites on El component.
Although HE=TPP is made at the reductive acetylation active site
on El component, phosphorylation inhibits the translocation of
HE=TPP to decarboxylation active site where it reacts with
acetaldehyde, therefore acetoin can not be made. Also the
reductive acetylation reaction requires the attachment of the El
component to a binding region on the E2 subunit to bring enzyme
components to the best proximity to catalyze the reaction. The
reductive acetylation reaction requires structure of the lipoyl
domain of the E2 subunit. Because phosphorylation of El component
may cause improper positioning of El component on E2 subunits, it
is likely that the lipoyl domain of E2 subunit is not able to
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enter the reductive acetylation active site properly on El
component and the transfer of acetyl group between El and E2
subunits can not be efficiently accomplished.
New evidence has suggested that an acetyl-TPP is formed as an
intermediate from the oxidation of HE=TPP, with the concomitant
reduction of the lipoyl moiety of the E2 subunit. Phosphorylation
may also block the formation of acetyl-TPP from HE=TPP or the
subsequent transfer of the acetyl group to the reduced lipoyl
moiety. The mechanism of PDC activity inhibition by
phosphorylation still remains to be further studied.
Stepp et al . (7) found that PDC could be inactivated by
pyridoxal 5'-phosphate, and the reaction site of pyridoxal 5'-
phosphate was determined to be a lysine residue of the El a
subunit (7). Also, as mentioned above, phosphorylation of El
component markly inhibited the reaction 1 but did not inhibit the
reaction 2 (6). Since the a subunit of the El component undergoes
phosphorylation, it was assumed that El a subunit was the
functional subunit to catalyze the pyruvate decarboxylation
reaction (reaction 1) and El subunit was the one to catalyze the
reductive acetylation reaction (reaction 2) based on the above
observations.
To attempt to establish El subunit catalytic functions, El 3
fraction was studied using the reverse of the reductive
acetylation reaction. The failure of El g subunit to restore
reconstitution activity with E2 and E3 components indicated that
El 6 alone was not able to catalyze reaction 2. Since El a
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subunit is not available to examine the reconstitution activity,
the conclusion can not be made. But it is most likely that active
site resides between a and (3 subunits of El and requires both
subunits to function.
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Fi gure 2-1. Coordinated reactions catalyzed by pyruvate
dehydrogenase complex.
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Fi gure 2—2. Forward and reverse reaction steps involving
hvdroxyethvl thiamin pyrophosphate (HETPP).
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H+ E2-LipS2
—> E1-HE=TPP —-^» > E2-CH3CO-SLipSH
J
El <- T
TPP
-El-TPP'
Forward reaction
E2-LipS2
E3
NADH + H+
NAD+
E2-Lip(SH) 2
CH3COSC0Ar
CoASH
E2-CH3C0SLipSH El-TPP
E2-LipS 2
CH3CH(OH)COCH3
(acetoin)
E1-HE=TPP CH3CHO
Reverse reaction
4,5
Fi gure 2-3. HPLC profile of acetoin.
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Fi gure 2-4. Time course of acetoin production by reverse
reductive acetvlation reaction. Data represents nmole of acetoin
produced in the assay mixture of 0.1 ml (refer methods for details
in the text).
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Chapter 3
Effects of Extrinsic Factors
on Pyruvate Dehydrogenase Complex
INTRODUCTION
Since pyruvate dehydrogenase complex catalyzes the reactions
that serve both bioenergetic and biosynthetic roles, the
regulation of this enzyme complex is of central importance to the
energy balance and fuel economy of animal cells. The stimulation
of PDC activity is one of the major sites of insulin regulation.
Insulin was the first peptide hormone isolated and sequenced and
the three dimensional structure elucidated. While many hormones
which bind to cell surface receptors activate a second messenger
generation system, it still remains largely unknown how insulin
exerts the diverse effects on the intracellular regulation and
function after it binds to the receptor on the plasma membrane.
Over the past 20 years, a large number of attempts have been made
to clarify the biological pathways involved in insulin signal
transduction (12).
Some investigations have focused on free intramitochondrial
Ca2+
,
since it has been found that Ca2+ is the second messenger
for several other hormones (a-adrenergic agonists, vasopressin,
angiotensin etc.). However Denton's laboratory has presented
evidence that the PDC activation by insulin does not involve an
increase in free intramitochondrial Ca2+ concentration (4). Some
other proposed mechanisms have also been proved not to be
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primarily responsible for mediating the action of insulin. Since
late 1970 's and early 1980' s, researchers have concentrated on
looking for an insulin-dependent second messenger. After Jarett's
laboratory presented evidence for a mediator of insulin effects on
PDC (5,14), several other laboratories also presented the results
supporting such modulator(s) (7,13). The mediator(s) found has
been reported to be capable of regulating the activities of
several insulin-sensitive enzymes such as PDC, cAMP
phosphodiesterase (PDE), adenylate cyclase, etc. (5,8,9,10,13,14).
The apparent molecular weight of the putative mediator(s) was
determined to be about 1000 by gel permeation chromatography (8).
The properties of the putative mediator(s) include net negative
charge, stabililty to acid, and inactivation by chemical
modification (12). Further studies support an inositol phosphate
glycan structure based on the chemical properties (9,10). It is
suggested that such mediators originated from the plasma membrane
and might be released into the cytoplasm upon insulin binding to
the receptor (8,9,10). The precursor(s) of the mediator(s) is
thought to be anchored in the plasma membrane through a
phosphodiester linkage between diacylglycerol and inositol (12).
The generation of these substances from membranes by insulin can
be reproduced by addition of a phosphatidyl inositol-specif ic
phospholipase C (PIPLC) which acts on the linkage and releases the
soluble glycan structure (9). This suggests that insulin may
activate an intrinsic phospholipase C upon its binding to the
receptor which in turn selectively hydrolyzes
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phosphatidylinositol, releasing certain inositol phosphate glycan
structures. In fact, an enzyme with these properties was found in
the rat liver membrane fraction purified by Fox et al . (2).
Recently, Saltiel et al . (11) demonstrated that the addition of
IPG and PIPLC into adipocytes caused an increase in lipogenesis
and glucose oxidation. These results suggest that IPG added or
released from the adipocytes might serve as a second messenger.
Since PDC can be activated by insulin and this activation has
been suggested to be achieved by either inhibition of kinase or
activation of phosphatase or both (1), several studies on the
insulin mediators have been conducted on PDC system. Seals and
Jarret (14) showed that addition of insulin to a mixture of plasma
membrane and mitochondria resulted in a decrease in the
phosphorylation of the El a subunit (14). Jarret later provided
the evidence that the activation of PDC by insulin-generated
mediator was due to the stimulation of PDH phosphatase (3).
Based on the present knowledge about insulin mediator, we
have attempted to confirm observations on PDC that have been
observed in other laboratories. The major goal of this study is
to determine whether the PIPLC treated membrane fraction which
presumably contains the potential messenger for mediating insulin
induced activation of PDC, acts directly on the purified
phosphatase or requires additional components present in
responsive mitochondria. We also investigated the effects of
extrinsic factors on the PDC activity in adipocytes.
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MATERIALS AND METHODS
Materials: Male Sprague Dawley rats (100-150 g) were from
Sasco. Highly purified PDC (15-18 umole/mg/min) was used.
Phosphatase was partially purified using DEAE—Sepharose column.
Collagenase (type II) was purchased from SIGMA, [ 1—^^C] pyruvate
(sodium salt) was from New England Nuclear (NEN) Du Pont Company,
myo—inositol 2—monophosphate (IP) was purchased from SIGMA.
Isolated insulin mediator fractions and phosphatidylinositol—
specific phospholipase C (PIPLC) were generously provided by Dr.
Ruth Welti from Division of Biology. All other chemicals used
were highest grade available.
Brief mediator preparation steps: Mediator fractions were
prepared in Dr. Ruth Welti's laboratory following the procedure
described by Saltiel et al . (9). A particular fraction of rat
liver membrane was purified by centrifugation. This fraction was
lyophilized and resuspended in acetate buffer, pH 4.5, then
treated with PIPLC. After incubation, samples were acidified to
pH 4.0, lyophilized and redissolved in deionized water, pH 7.0-
7.5. This was the crude mediator fraction. Further purification
steps were performed by DEAE-cellulose column, C^g reverse-phase
resin, Dowex AG 50W-X-4 anion-exchange resin, QAE-Sephadex column
and Bio-Gel P-2 column. The fractions were lyophilized and
resuspended in 50 mM formic acid.
Phosphatase assay: Typically the assay was conducted in a
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mixture containing 30 mM MOPS-K"1", pH 7.5, 0.8 mM EDTA, 2 mM MgCl2,
2.2 mM CaCl2 and 2 mM EGTA (ethyleneglycol-bis-tetraacetic acid).
Phosphorylated PDC, phosphatase and insulin mediator fractions
were added at the indicated amounts. The reaction mixture was
preincubated without the presence of Mg^+ and Ca2+ at 30°C for 1
min. The reaction was initiated by adding Mg^+ and Ca^+ and
further incubated for 2 min. Total volume of each assay was 20
ul. A control was done without Mg^+ and Ca^4". 10 ul was
withdrawn and added into a temperature equilibrated cuvette at
30°C containing 2 mM MgCl 2 , 2 mM NAD4", 0.2 mM thiamin-PP, 50 mM
KXP04, pH 8.0, 62.5 uM CoA, 1.32 mM cystein-HCl and 2 mM pyruvate.
The absorbance change rate at 340 nm was monitored.
Rat liver mitochondria isolation: The preparation of rat
liver mitochondria essentially followed the procedure described by
Saltiel et al
. (7). All the steps were conducted at 4°C. Rat
livers were rinsed three times in 20 mM KxP0z,, pH 7.4, then
chopped into small pieces, homogenized in 10 volumes of buffer A
pH 7.2 (0.21 M mannitol, 75 mM sucrose, 1 mM tris, and 0.1 mM
EDTA). They were centrifuged at 500xg for 10 min, and the pellet
was discarded. The supernatant was centrifuged at 9000xg for 10
min, and the pellet was resuspended in equal volume of buffer A.
The above two centrifugation steps were repeated once. The pellet
was swollen to open the inner mitochondria membrane to enhance the
enzyme sensitivity by adding 10 volumes of buffer B pH 7.2 (20 mM
KxP04 with °' 02 % BSA w/v) gradually over 45 min, while the pellet
54
was gently agitated frequently. Then 2 ug/ml oligomycin was added
to the mitochondria. To inactivate the PDC in mitochondria, the
suspension was incubated with 0.2 mM ATP at the presence of 50 uM
MgCl2 and CaCl2 at 30°C for 10 min, then centrifuged at 30,000xg
for 30 min to remove the excess ATP. The pellet was resuspended
in buffer B and centrifuged again at 1900xg for 15 min. The final
pellet was resuspended in buffer B, aliquoted and stored at -70°C.
The protein concentration was measured by Biuret method.
Rat adipocyte isolation: The adipocytes were isolated by the
procedure of Rodbell (6) with modification. Rat epidermal fat
pads were rinsed in 0.85% NaCl and then put in 3 volumes of Krebs-
Ringer buffer with 3% (w/v) BSA and 5 mM glucose, chopped into
fine pieces. Collagenase (5 mg/g fat pad) was added into the
mixture. The tube was flushed with 5% CO2, 95% O2 gas mixture and
digested at 37°C in the water bath for one hour with shaking. The
suspension was then passed through a nylon mesh to collect the
adipocytes. After a brief spin (15 s) in the clinical centrifuge
the cells floated to the top and the solution was carefully
removed from the bottom. Cells were washed 3 times with 10 ml
warm Krebs-Ringer buffer and finally suspended in an appropriate
amount of the same buffer. 2 ml aliquots of cells were
distributed to flasks and gassed with 5% CO2, 95% O2 mixture. The
flasks were sealed and incubated at 37°C in a shaking water bath
for 40 min to allow the insulin receptors to recover. Further
incubation was conducted at same the temperature for 1 h with
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extrinsic factors. The cells were broken using a Tekmar
homogenizer and then transferred into eppendorf tube. The
mitochondria were centrifuged three min by minifuge (8000xg). The
pellets were resuspended in 0.8 ml stop solution (20 mM KxP0^, pH
7.5, 20 mM EDTA, 50 mM NaF, 4 % (v/v) Triton X-100 and 10 mM
dichloroacetic acid (DCA)) and stored at -70°C.
Pyruvate dehydrogenase assay; For rat liver mitochondria PDH
assay, the frozen sample was thawed and typically 0.5-0.6 mg
protein was added to each assay mixture containing 1 mM DTT, 0.05
mM MgCl 2 , 0.05 mM CaCl 2 , 20 mM KxP04 , pH 7.5 in final volume of 1
ml. The mediator fractions were added to the mixture at indicated
levels and incubated at 37°C for 10 min. The full activation
extent of PDC was determined by incubating mitochondria with 20 mM
MgCl2 and 0.5 mM CaCl2. Then 0.2 ml of incubation mixture was
added into the temperature equilibrated (30°C) tube containing 2.0
mM CoA, 10 mM DTT, 2.5 mM NAD+, 0.25 mM TPP, 5 mg/ml BSA, 50 mM
KxP04> PH 7 - 5 » 2 mM MgCl 2 and 4% Triton X-100. For the adipocyte
mitochondria assay, the samples were thawed and 0.2 ml aliquots
were added into the same solution. The mitochondria were
preincubated for 1 min and the reaction was initiated by adding
220 nM [1- 14C] pyruvate (5000 cpm/nmole). The samples were sealed
with a rubber cap with a plastic well attached to it. After 2 min
the samples were placed in isopropanol-dry ice to stop the
reaction. 0.2 ml B-phenylethylamine was injected on the filter
paper in the plastic well. Radiolabeled CO2 was released from the
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solution by shaking at 37°C in the water bath for 30 min and
absorbed by the filter paper, the plastic well was cut into the
scintillation fluid and counted. All the samples were done in
triplicate.
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RESULTS AND DISCUSSION
The, effect s of mediator fractions on phosphatase activity.
Non-PIPLC treated and PIPLC treated crude fractions (see
methods) which were prepared in Dr. Welti's laboratory were tested
on PDC phosphatase assay. Low Mg^+ concentration (1^) was used in
the phosphatase assay. Initially 1 ul PIPLC treated fraction
activated phosphatase activity by 60%, whereas the same amount
without PIPLC treatment inhibited the activity by 34% compared
with control (Table 3-1). When assayed with fresh phosphatase
even further activation up to 190% was observed, and the fraction
without treatment of PIPLC showed 65% inhibition (Table 3-1).
However it seemed that the mediators were not very stable; the
extent of activation ranged from 80% to 190% of the control value.
The same PIPLC treated fraction was used at different
concentrations to investigate the effect on phosphatase
activation. When 0.5 ul and 1.0 ul of the PIPLC treated fraction
were tested, 39% and 50% activations were observed respectively.
However when the amount increased to 2.0 ul, it inhibited the
activity by 61% (Table 3-1). As a biphasic tendency was observed,
further characterization of both PIPLC treated fraction as well as
untreated fraction was performed (Figure 3-1). PIPLC treated
fraction at different concentrations exhibited a biphasic
response. This agrees with the Saltiel's observation that the
activation increases in proportion to the concentration of the
mediator fraction and then declined at high concentrations (7).
Saltiel suggested that this resulted from the existence of two
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opposing substances. They provided the evidence by separating
them by ethanol extraction. The ethanol—extracted residue
(aqueous phase) had a consistent dose dependent stimulatory
effect, whereas the ethanol-extractable (organic phase) gave a
dose dependent decrease in the PDH activity. It seems that this
could be a plausible explanation for the observation obtained from
PIPLC treated fraction. But the fraction without the treatment of
PIPLC also exhibited a biphasic pattern that was similar to PIPLC
treated fraction, with the highest activation (86%) being shifted
to the higher concentration (Figure 3-1). The reason why this
happened is not known.
It has been determined that phosphatase activity requires
millimolar Mg2+
,
is increased by micromolar Ca2+ . The Y^ for Mg2+
is 2-5 mM. In order to determine whether the observed activation
by mediator fraction was Km or Vmax effect, titration of Mg2+ were
done with and without the addition of PIPLC treated fraction on
phosphatase assay (Figure 3-2). The extents of phosphatase
activation by PIPLC treated fraction were large (45-66%) and only
observed at very low Mg2+ concentrations (0.2-0.3 mM). At higher
Mg^ concentrations, a large phosphatase activation effect was not
achieved. One obvious problem was that the effects were only seen
at low (nonphysiological) Mg 2+ concentrations. This may be
attributed to the contamination of metal ions in the mediator
fraction. However, over the entire range of Mg2+ tested, a
consistently higher level of phosphatase activity was observed
when assayed with PIPLC treated fraction. Furthermore, the
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mediator fraction alone (i.e. in the absence of added Mg^+ , but in
the presence of Ca^+ ) failed to support any phosphatase activity
(data not shown)
.
The effects of mediator fractions on PDC activity in mitochondria.
Both crude and further purified mediator fractions were
tested with rat liver mitochondria. The mitochondria were
prepared in a way so that the inner membrane was permeablized to
enhance the enzyme sensitivity. The PDC in such prepared
mitochondria was inactivated by ATP treatment and maintained the
ability to be fully reactivated at the presence of Mg^+ and Ca^+
.
Typically, a 15-fold increase in the activity of the PDC of ATP-
treated mitochondria was obtained by high concentration of Mg^+
and Ca^+ . Fractions that were observed in Dr. Welti's lab to
activate PDE were tested, but only limited effect (<10%) on PDC
assay was observed. Considering its potential ability to be
reactivated, the results were not encouraging. Other fractions
were examined and hardly showed any sign of activation. It is
possible that the mediator concentrations used in these assays
were not appropriate for giving maximum activation. Due to the
time consumed to prepare the mediator and the limited material
available, the study was not carried out further.
The effects of extrinsic factors on PDC activity in adipocytes.
Saltiel et al
. (11) recently demonstrated that incubating
adipocytes with PIPLC increased the levels of lipogenesis and
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glucose oxidation. Their results suggested that IPG which could
mediate the insulin action was released from the plasma membrane.
Also a mediator analogue IP has exhibited the ability to block the
activation on lipogenesis and glucose oxidation by IPG. In this
study the same system was employed to study the influences of
insulin, IP and PIPLC on PDC activity (Table 3-1). Insulin
activated the PDC activity with adipocyte cells increased but not
as much as reported by others (e.g. 200% (1)). It is possible
that during the collagenase digestion of fat tissues, the insulin
receptors on the cell surface were partially impaired and not
fully recovered during the recovery period. Two other experiments
done with the addition of PIPLC yielded conflicting results (Table
3-II). PIPLC (1 ug/ml) alone and in combination with IP and
insulin exhibited inhibitions compared to their respective
controls. In a separate experiment, however, two concentrations
of PIPLC (1 Ug/ml, 2 yg/ml) were tested and they both showed an
activation of near 30%.
The results from this study only represent some preliminary
observations. It is still not well understood how insulin
mediator regulates PDC activity. It seems that the putative
insulin mediator is not very stable, since the same fraction used
in the assay showed various activity at different times.
Additionally the insulin mediator preparation procedure is time-
consuming and the release of it can not be easily monitored during
the isolation process. This can probably be improved by
introducing radioactive label in the precursor of the mediator,
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therefore its production is followed by radioactivity. Certainly,
more investigation is needed in the future.
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Fi gure 3—1. The effect of fractions treated with and without
PIPLC on the activity of phosphatase. The phosphatase assay was
carried out with 20 ug phosphorylated PDC and 0.3 ug phosphatase.
The reaction was initiated by adding 2 mM MgCl2» Open circle
represents the assays done with the PIPLC treated membrane
fraction; Filled circle represents the assays conducted with the
non-PIPLC treated membrane fraction (control). PIPLC treated and
non—PIPLC treated membrane fractions used in this study were crude
fractions (see methods in the text).
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Fi gure 3-2. The activation of phosphatase activity at
different Mg^+ concentration with and without PIPLC treated
membrane fraction. The phosphatase activity was assayed with 20
ug phosphorylated PDC, 0.2 ug phosphatase at lower [Mg^+ ] and 0.1
Ug at higher [Mg2+ ] , 0.5 ul PIPLC treated membrane fraction was
used (open circle); assays done without PIPLC treated membrane
fraction (control; filled circle). Crude PIPLC treated membrane
fraction was used (see methods in the text).
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Table 3-1. Effects of PIPLC treated and non-PIPLC treated
membrane fractions on phosphatase activity.
Fraction
PIPLC treated fraction21
Non-PIPLC treated fraction3
PIPLC treated fractionb
Non-PIPLC treated fractionb
PIPLC treated fraction
Phosphatase
Volume (111) Activity vs
control (%)
1.0 152
1.0 163
1.0 66
1.0 223
1.0 290
1.0 182
1.0 35
0.5 139
1.0 150
2.0 39
aThe phosphatase assayed with (0.3 ug) was 'old'
b0.2 ug fresh phosphatase was used.
c0.3 ug phosphatase was assayed.
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Table 3-1 I. Effects of extrinsic factors on PDC activity in
adipocytes. 2 ml of adipocytes (3.8xlO-Vml) were incubated with
each extrinsic factor or combination of them at 37°C for 1 hour,
then mitochondria were isolated and assayed for PDC activity.
Extrinsic Factor PDC Activity vs.
control (%)
Insulin
0.5 nM
1.0 nM
2.0 nM
5.0 nM
IP (1 mM)
PIPLC
1 Ug/ml
3 ug/ml
IP (1 mM) + Insulin (1 nM)
IP ( ImM) + PIPLC (1 ug/ml)
Insulin (1 nM) + PIPLC (1 ug/ml
)
a
PIPLC (1 ug/ml) + Insulin (1 nM) b
145 (130) c
148 (136) c
143 (145) c
136 (122) c
127
81 (133) c
(132) c
153
138
111
112
a Insulin was preincubated with adipocytes for 3 minutes then
PIPLC was added.
"PIPLC was preincubated with adipocytes for 3 minutes then
insulin was added.
cResults obtained from a separate experiment, 2ml of adipocytes
(9xl0-Vml) were used.
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ABSTRACT
1
.
Through the resolution of purified bovine kidney pyruvate
dehydrogenase complex (PDC), the following were prepared:
dihydrol ipoyl transacetylase-protein X-kinase (E2-X-K cKb)
subcomplex, protein X-kinase (X-KCK^) fraction, E2 with inner
domain of protein X (E2-Xj) subcomplex in which the outer domain
of protein X was selectively removed and E2 oligomer with most
protein X removed (E2")« The fractions containing E2 and the X-
K cKb fraction were incubated and centrifuged. Sodium dodecyl
sulfate gel electrophoresis of pellet fractions showed a
significant increase in the binding of the catalytic subunit of
the kinase (Kc ) to E2 core, while the ratio of E2 to protein X
stayed nearly the same. There was also increased binding of Kc to
E2-Xj and E2" subcomplexes, indicating that the binding of kinase
to E2 is independent of protein X. These results provided
evidence that 16 kinase molecules could be bound directly to the
E2 core.
2. The reverse of the reductive acetylation reaction was
studied through a coupled reaction involving the formation of
acetoin through the reaction of the 2-(l-hydroxyethylidene)-
thiamin pyrophosphate intermediate with acetaldehyde. The
reaction rate was 0.11 umole/mg/min. The phosphorylated PDC
completely inhibited acetoin production. Following proteolytic
cleavage of the El a subunit, the possibility that the 6 subunit
of the El component upon reconstitution with E2 and E3 would
catalyze the reductive acetylation reaction was evaluated. The
negative result indicates the El 8 subunit alone is not sufficient
for catalyzing this reaction.
3. Phosphoinositol-specif ic phospholipase C (PIPLC) has been
proposed to release from the plasma membrane a soluble
inositolphosphate glycan that activates the PDC activity. The
effects of PIPLC treated membrane fractions on the activation of
PDC were investigated. The effects of the fractions were
evaluated for their capacity to increase the activity of the
purified pyruvate dehydrogenase phosphatase and to activate PDC in
rat liver mitochondria and rat adipocytes. Some activation of
phosphatase was observed with the phosphatase assay, but the
extent of activation varied.
